首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolu
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolu
admin
2013-11-29
115
问题
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolution is based on the idea that the sicker people are, the more freedom they should have to try drugs that are not yet fully tested. For fifty years government policy has been driven by another idea: the fear that insufficiently tested medicines could cause deaths and injuries. The urgent needs of people infected with HIV, the AIDS virus, and the possibility of meeting them with new drugs have created a compelling countervailing force to the continuing concern with safety. As a result, government rules and practices have begun to change. Each step is controversial. But the shift has already gone far beyond AIDS. New ways are emerging for very sick people to try some experimental drugs before they are marketed. People with the most serious forms of heart disease, cancer, emphysema, Alzheimer’ s or Parkinson’ s disease, multiple sclerosis, epilepsy, diabetes, or other grave illnesses can request such drugs through their doctors and are likelier to get them than they would have been four years ago. "We’ve been too rigid in not making lifesaving drugs available to people who otherwise face certain death," says Representative Henry Waxman, of California, who heads the subcommittee that considers changes in drug-approval policies. "It’s true of AIDS, but it’s also true of cancer and other life- threatening diseases."
For the first time, desperate patients have become a potent political force for making new medicines available quickly. People with AIDS and their advocates, younger and angrier than most heart-disease or cancer patients, are drawing on two decades of gay activists’ success in organizing to get what they want from politicians. At times they found themselves allied with Reagan Administration deregulators, scientists, industry representatives, FDA staff members, and sympathetic members of Congress. They organized their own clinical trials and searched out promising drugs here and abroad. The result is a familiar Washington story: a crisis—AIDS—helped crystallize an informal coalition for reform.
AIDS gave new power to old complaints. As early as the 1970s the drug industry and some independent authorities worried that the Food and Do, g Administration’ s testing requirements were so demanding that new drugs were being unreasonably delayed. Beginning in 1972, several studies indicated that the United States had lost its lead in marketing new medicines and that breakthrough drugs—those that show new promise in treating serious or life-threatening diseases— had come to be available much sooner in other countries. Two high-level commissions urged the early release of breakthrough drugs. So did the Carter Administration, but the legislation it pro- posed died in Congress. Complaints were compounded by growing concern that "if we didn’t streamline policies, red tape wot, Id be an obstacle to the development of the biotechnology revolution," as Frank E. Young, who was the head of the FDA from 1984 to 1989, put it in an interview with me.
Young was a key figure in the overhaul of the FDA’s policies. A pioneer in biotechnology and a former dean of the University of Rochester’s medical school, he came to Washington with an agenda and headed the agency for five and a half years—longer than anyone else has since the 1960s. Young took the FDA job to help introduce new medicines created by biotechnology-- whose promise he had seen in his own gene-cloning lab--and to get experimental medicines to desperately iii people more quickly. He had seen people die waiting for new medicines because "they were in the wrong place at the wrong time," he said. That is now changing.
It can be said that the people who first started the quiet drug revolution are ______.
选项
A、doctors
B、government officials
C、AIDS patients
D、pharmacologists
答案
C
解析
转载请注明原文地址:https://www.kaotiyun.com/show/lHhO777K
0
考博英语
相关试题推荐
AmericaLosesaGreatPublicThinkerArthurMiller’sdeathlastweekmeantmorethanthelossofanoutstandingplaywright.
Thelawofprivateinternationaltribunalswithrespecttoconflictsofinterestofarbitratorsisquiteextensive,albeitbyno
Themarveloustelephoneandtelevisionnetworkthathasnowenmeshedthewholeworld,makingallmenneighbors,cannotbeextend
InmostSouthAmericancountriesrailtransportisplaguedbyoperationalproblemsaswellasbyobsoleteequipment.
Justiceinsocietymustincludebothafairtrialtotheaccusedandtheselectionofanappropriatepunishmentforthoseproven
BetweentheinventionofagricultureandthecommercialrevolutionthatmarkedtheendoftheMiddleAges,wealthandtechnology
Inaperfectlyfreeandopenmarketeconomy,thetypeofemployer--governmentorprivate-shouldhavelittleornoimpactonthe
Itis3A.M.everythingontheuniversitycampusseemsghostlikeinthequiet,mistydarkness-everythingexceptthecomputerce
MorethanhalfofallJewsmarriedinU.S.since1990havewedpeoplewhoaren’tJewish.Nearly480,000Americanchildrentrader
Writeanessayofnolessthan250wordsongiventopicOnWorkingTogether.Youshouldwriteneatly’ontheANSWERSHEET.1.我们在
随机试题
电阻器的识别主要根据它的结构特点进行判定。()
阅读全诗,回答下列问题:我来了,我喊一声,进着血泪,“这不是我的中华,不对,不对!”我来了,因为我听见你叫我;鞭着时间的罡风,擎一把火,我来了,不知道是一场空喜。我会见的是噩梦,哪里是你?
A.婴儿期B.幼儿期C.学龄前期D.学龄期E.青春期认识到子女的发育特点,对孩子给予充分的理解和尊重,是重要的建立亲子关系的方法,是在
采用()措施消除和降低粉尘危害,是治本的对策,是防止尘肺发生的根本措施。
学校教育的基本途径有【】
材料:越来越接近精神的天空李汉荣人,在人群里行走寻找他的道路,在人群里说话寻找他的回声,在人群里投资寻找他的利润,在人群里微笑寻找回应的表情。生而为人,我们不可能拒绝人群,虽然,喧嚣膨胀的人群有时是那么令人窒息,让人沉闷,但我
下列选项中,按照诗句所代表的二十四节气先后顺序排列正确的是()。①问东城春色,正谷雨,牡丹期②露从今夜白,月是故乡明③微雨众卉新,一雷惊蛰始④麦穗初齐稚子娇,桑叶正肥蚕食饱
根据以下资料。回答以下题。2010年,全国国有建设用地土地供应总量42.8万公顷,比上年增长18.4%。其中,工矿仓储用地15.3万公顷,增长7.9%;商服用地3.9万公顷,增长40.4%;住宅用地11.4万公顷,增长40.3%;基础设施等其他用地12
(1)上班迟到(2)晚上加班到深夜(3)心中难受(4)领导批评(5)工作任务繁重
(2009下架构)公司总部与分部之间需要传输大量数据,在保障数据安全的同时又要兼顾密钥算法效率,最合适的加密算法是______。
最新回复
(
0
)